随着选择性培养技术的发展,空肠弯曲杆菌已被视为细菌性胃肠炎的一种主要病原。在很多国家它的发病率已等于或超过沙门氏菌病和志贺氏病的发病率。空肠弯曲杆菌通常在体外对红霉素敏感。一些研究者曾报告,用红霉素治疗可改变弯曲杆菌胃肠炎的临床过程,因此,临床上开始应用红霉素治疗本病。作者进行了以安慰剂作对照的红霉素临床双盲研究,试图确定红霉素治疗急性弯曲杆菌肠炎的作用。病人均选自粪便弯曲杆菌培养阳性的肠 With the development of selective culture techniques, Campylobacter jejuni has been considered as a major causative agent of bacterial gastroenteritis. Its incidence has equal or exceeded Salmonella and Shigella morbidity in many countries. Campylobacter jejuni is usually sensitive to erythromycin in vitro. Some researchers have reported that treatment with erythromycin can change the clinical course of Campylobacter gastroenteritis, therefore, the clinical application of erythromycin in the treatment of this disease. The authors performed a placebo-controlled clinical double-blind study of erythromycin in an attempt to determine the role of erythromycin in the treatment of acute Campylobacter [iota] nitis. All patients were selected from Campylobacter cultivated positive intestines